Latest News and Press Releases

NAARDEN, The Netherlands, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Forbion, a leading global life sciences venture capital firm with deep roots in Europe, is pleased to announce the promotion of Joy...

Jon Edwards, PhD, joins Forbion as Partner in Boston to drive North American investments and support portfolio companies.

Forbion has led the €18 million Series A financing round through its BioEconomy fund of German tech startup EEDEN GmbH.

Forbion’s BioEconomy Fund I has raised €164.5 million to date, exceeding its €150 million target in just over a year, since launching in November 2023.Institutional investors, include KfW Capital,...

Forbion’s largest fundraising to date with Forbion’s Growth Opportunities Fund III raising €1.2 billion & Forbion Ventures Fund VII raising €890 million

Josh Brumm, previously CEO of Dyne Therapeutics, appointed as General Partner at Forbion. Brumm to be located at Forbion's new Boston office.

Forbion announces the first close of its latest fund, Forbion BioEconomy Fund I (“Forbion BioEconomy"), at €75 million.

Successful fundraising demonstrates value of Forbion platform, with multiple Forbion fund strategies supporting VectorY’s development since launch

Forbion co-leads oversubscribed Series B financing in next-generation radiopharmaceuticals companyFirst investment by its Forbion Ventures Fund VI, aimed at advancing highly impactful...

Leading institutional investors commit $135 million USD in transaction financing, anchored by FEAC’s sponsor, Forbion Growth Sponsor FEAC I B.V. (together with its parent entity Forbion Growth...